DRESIS 2.0: the comprehensive landscape of drug resistance information
Nucleic Acids Research · 06.01.2026 · 54 (D1) · D1387-D1396
DOI: 10.1093/nar/gkaf1219 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 20.11.2025. Verfasst von Xiuna Sun und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology Head and Neck Surgery, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Zhejiang University, Hangzhou …. Hauptthemen laut MEDLINE: Drug Resistance, Neoplasm, Drug Resistance, Software. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Natural Science Foundations of Zhejiang, National Natural Science Foundation of China, National Key R&D Program of China.
Abstract (Originalsprache)
Elucidating mechanisms of drug resistance is key for overcoming resistance, guiding drug design, and enabling accurate resistance prediction. Recently, disease metabolic reprogramming has emerged as a novel mechanism of resistance, which enables disease cells to adapt to therapeutic resistance by altering energy production pathways, cellular signaling, and biosynthesis processes. Moreover, protein structure alterations also play a pivotal role in resistance study, facilitating mechanistic understanding, and structure-based target discovery. In other words, integrating these recently accumulated critical data is essential for enriching the landscape of drug resistance data. Therefore, in this study, DRESIS was a significant update by providing (i) 236 molecules that drive metabolic reprogramming and confer resistance to 168 drugs, together with a detailed mechanism, (ii) 2228 protein structural variants implicated in resistance to 671 drugs across 238 diseases, and (iii) greatly expanded landscapes of drug resistance information, now featuring 398 newly added key drug-resistant molecules, 356 drugs with the latest published resistance mechanisms, and 81 new drug-resistant disease categories. All in all, DRESIS 2.0 is expected to serve as a valuable resource for the scientific community and provide important support in tackling the global challenge of drug resistance, which is now publicly accessible at https://idrblab.org/dresis/
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Otolaryngology Head and Neck Surgery, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Zhejiang University, Hangzhou 310058, China.
- College of Pharmaceutical Sciences, The Second Affiliated Hospital, Zhejiang University School of Medicine, State Key Laboratory of Advanced Drug Delivery and Release Systems, Zhejiang University, Hangzhou 310058, China.
- Innovation Institute for Artificial Intelligence in Medicine of Zhejiang University, Hangzhou 330110, China.
- Key Laboratory of Biotechnology Pharmaceutical Engineering, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou 325035,China.
- Key Laboratory of Biotechnology Pharmaceutical Engineering, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou 325035, China.
ORCID-Profile: Yintao Zhang, Mang Xiao, Feng Zhu
Förderung
- Natural Science Foundations of Zhejiang
- National Natural Science Foundation of China
- National Key R&D Program of China
Zitieren
APA
Sun, X., Wei, Z., Yu, X., Liu, K., Yao, S., Ni, Z., Wang, H., Zhao, Z., Zhang, Y., Liu, Y., Ding, H., Zhang, Y., Liu, Z., Xiao, M., & Zhu, F. (2026). DRESIS 2.0: the comprehensive landscape of drug resistance information. Nucleic Acids Research, 54(D1), D1387-D1396. https://doi.org/10.1093/nar/gkaf1219
Vancouver
Sun X, Wei Z, Yu X, Liu K, Yao S, Ni Z, et al. DRESIS 2.0: the comprehensive landscape of drug resistance information. Nucleic Acids Research. 2026;54(D1):D1387-D1396. doi:10.1093/nar/gkaf1219
BibTeX
@article{Sun2026,
author = {Sun, Xiuna and Wei, Zhangle and Yu, Xinyuan and Liu, Kaixuan and Yao, Shun and Ni, Zheng and Wang, Hanbing and Zhao, Ziming and Zhang, Yinpeng and Liu, Yuxuan and Ding, Hanlu and Zhang, Yintao and Liu, Zhiguo and Xiao, Mang and Zhu, Feng},
title = {DRESIS 2.0: the comprehensive landscape of drug resistance information},
journal = {Nucleic Acids Research},
year = {2026},
volume = {54},
number = {D1},
pages = {D1387--D1396},
doi = {10.1093/nar/gkaf1219}
}
EUVIMED